New Horizon Medical Solutions acquires transparent negative pressure wound therapy device and micro grafting kit to enhance its industry-leading portfolio of wound care solutions
LAS VEGAS, NV / ACCESS Newswire / December 29, 2025 / New Horizon Medical Solutions (NHMS) is excited to announce the acquisition of Applied Tissue Technologies’ (ATT) business assets. ATT is a pioneering, 25-year-old wound care company based in Boston, Massachusetts. This strategic move aligns with NHMS’s commitment to delivering cutting-edge products that enhance wound care management.
Key acquisition highlights
Novel wound technologies
ATT has developed patented treatment methods and proprietary devices that empower caregivers to heal wounds more efficiently. Their technologies are designed for use in both established economic zones and in underserved areas, using non-powered and battery-powered solutions.
Expert leadership
Elof Eriksson, MD, PhD, founder of ATT and a distinguished figure in the field of plastic and reconstructive surgery, has been instrumental in the development of these innovative products. He served as chief of plastic and reconstructive surgery at Brigham and Women’s Hospital in Boston from 1986 to 2016 and held the prestigious Joseph E. Murray chair of plastic and reconstructive surgery at Harvard Medical School.
Revolutionary wound dressing
Dr. Eriksson states, “We have developed a novel, simpler, and more predictable wound dressing that features a transparency unlike any other in the marketplace, which is what providers have been searching for.”
Strategic vision
Will Hall, CEO of New Horizon Medical Solutions, remarked, “Together, these and other recent additions to our portfolio begin to distinguish us from others and make us a formidable industry partner.” This acquisition not only expands NHMS’s product offerings but also enhances its position as a leader in advanced wound care solutions.
About New Horizon Medical Solutions
New Horizon Medical Solutions (NHMS) is a leader in advanced wound care technologies, developing and delivering biologically derived human placental allograft products designed to meet the highest standards of safety, quality, and performance. The company’s portfolio includes amniotic membranes, placental tissues, and skin graft solutions for chronic wounds, surgical reconstruction, burns, and orthopedic procedures. NHMS has recently expanded its offerings to include advanced diagnostic imaging technologies through its partnership with Kent Imaging. Guided by evidence-based design, patient focus, and precision manufacturing, NHMS delivers solutions that support better clinical decision-making and improved patient outcomes.
www.nhmedical.com
About Applied Tissue Technologies
Applied Tissue Technologies brings advancements in wound healing to patients. This includes research and development supported by the United States Department of Defense to help wounded warriors at the point of injury, instances of prolonged field care and delayed evacuation, and continuing through advanced levels of military medical care. www.appliedtissue.com
Media contact
Julian Rogers
Director of Corporate Marketing
New Horizon Medical Solutions
Julian.rogers@nhmedical.com
702-960-2913
SOURCE: New Horizon Medical Solutions
View the original press release on ACCESS Newswire
SAN ANTONIO, Dec. 29, 2025 /PRNewswire/ -- Scott Leune Education today announced its 2026 sponsors,…
AUSTIN, Texas and TOKYO, Dec. 29, 2025 /PRNewswire/ -- According to DataM Intelligence, the Healthcare…
MESA, AZ / ACCESS Newswire / December 29, 2025 / Medical Care Technologies Inc. (OTC…
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…
Winter Park, Florida--(Newsfile Corp. - December 29, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a…